Mizuho keeps Belite Bio at outperform; raises target to $234
Mizuho maintained Belite Bio at outperform and raised its price target to $234.00 per share from $220.00,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.